ImmuCellvsThermo Fisher Scientific

ICCC and TMO stock compared: price, dividend, valuation and results, from SEC filings.

ICCC

ImmuCell Corporation

$10.75

Value $97M

+5.19%
ICCC's page

TMO

Thermo Fisher Scientific Inc

$700.22

Value $260B

+0.11%
TMO's page

ImmuCell (ICCC) has a market value of $97M and Thermo Fisher Scientific (TMO) $260B. Over the last year, with dividends, ICCC moved +75.4% and TMO +19.5%. The P/E is 51.7 for ICCC and 36.8 for TMO. Dividend yield: ICCC none, TMO 0.26%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ICCC$97M

    TMO$260B

    TMO is 2,675 times ICCC

  • Revenue, 12 months

    ICCC$33M

    TMO$47.4B

    TMO is 1,426 times ICCC

  • Net income, 12 months

    ICCC$1.9M

    TMO$7.1B

    TMO is 3,762 times ICCC

  • Operating margin

    ICCC14.5%

    TMO17.9%

    3.4 points apart

  • ROIC

    ICCC9.8%

    TMO8.2%

    1.6 points apart

  • P/E

    ICCC51.7

    TMO36.8

    ICCC is 1.4 times TMO

  • Dividend yield

    ICCC0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    ICCC+16.6%

    TMO+11.8%

    4.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ICCC+16.6%

TMO+11.8%

507510012520222023202420252026
Returns by period
PeriodICCCWith dividendsTMOWith dividends
1 year since November 12, 2025+75.4%Price +75.4%+19.5%Price +19.1%
3 years since November 13, 2023+106.7%+27.4% a yearPrice +106.7%+58.8%+16.7% a yearPrice +57.3%
5 years since November 12, 2021+16.6%+3.1% a yearPrice +16.6%+11.8%+2.3% a yearPrice +10.2%
10 years since November 15, 2016+111.6%+7.8% a yearPrice +111.6%+384.5%+17.1% a yearPrice +371.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ICCCImmuCellTMOThermo Fisher Scientific

Valuation

ICCCTMO
Valuation
Price$10.75$700.22
Market value$97M$260B
Enterprise value (EV)$97M$295B
P/E51.736.8
P/E, 5-year median–32.7
P/B3.04.8
EV/EBIT20.234.9
Free cash flow yield5.6%2.9%

Results and growth

ICCCTMO
Results and growth
Revenue, 12 months$33M$47.4B
Net income, 12 months$1.9M$7.1B
Free cash flow, 12 months$5.4M$7.6B
Earnings per share, 12 months$0.19$18.96
Revenue growth, year on year4.3%3.9%
Revenue growth a year, past+12.5%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

ICCCTMO
Margins and returns on capital
Gross margin40.8%–
Operating margin14.5%17.9%
Net margin5.7%14.9%
ROIC9.8%8.2%
ROE6.3%13.4%

Balance sheet

ICCCTMO
Balance sheet
Cash$7.9M$6.1B
Total debt$12M$41.4B
Net debt / EBITDA0.03.7
Interest cover12.2×5.5×

Dividends and buybacks

ICCCTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ICCC or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, ImmuCell or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($260B) is about 2,674.7 times ImmuCell ($97M), at today's prices.

How did ICCC and TMO stock do over the last 10 years?

Since November 15, 2016, ICCC's price moved +111.6% and TMO's +371.0%. With dividends: ICCC +111.6% (+7.8% a year), TMO +384.5% (+17.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, ICCC or TMO?

The dividend yield at today's price is none for ImmuCell and 0.26% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of ICCC and TMO?

At today's price, the P/E is 51.7 for ICCC and 36.8 for TMO. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, ImmuCell or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 5.7% for ImmuCell and 14.9% for Thermo Fisher Scientific, and the operating margin 14.5% and 17.9%. Revenue was $33M and $47.4B.

Which is the better investment, ImmuCell or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.